Πρόσφατες δημοσιεύσεις για ρευματικά νοσήματα και COVID-19
EULAR View-points on SARS-CoV-2 vaccination in patients with RMDs
https://www.eular.org/eular_sars_cov_2_vaccination_rmd_patients.cfm
Better outcomes of COVID-19 in vaccinated compared to unvaccinated patients with systemic rheumatic diseases
https://ard.bmj.com/content/early/2021/11/10/annrheumdis-2021-221539
https://ard.bmj.com/content/annrheumdis/early/2021/11/10/annrheumdis-2021-221539.full.pdf
Ann Rheum Dis: first published as 10.1136/annrheumdis-2021-221539 on 10 November 2021
Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort
https://ard.bmj.com/content/early/2021/03/24/annrheumdis-2021-220272
https://ard.bmj.com/content/annrheumdis/early/2021/03/24/annrheumdis-2021-220272.full.pdf
Ann Rheum Dis 2021;0:1–6. doi:10.1136/annrheumdis-2021-220272
Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience
https://link.springer.com/content/pdf/10.1007/s00296-021-04818-2.pdf
Rheumatol Int. 2021 Mar 3;1-7. doi: 10.1007/s00296-021-04818-2. Online ahead of print.
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
https://ard.bmj.com/content/early/2021/01/26/annrheumdis-2020-219498
https://ard.bmj.com/content/annrheumdis/early/2021/01/26/annrheumdis-2020-219498.full.pdf
Ann Rheum Dis. 2021 Jan 27; annrheumdis-2020-219498. doi: 10.1136/annrheumdis-2020-219498. Online ahead of print.
Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study
https://ard.bmj.com/content/early/2021/02/22/annrheumdis-2021-219845
https://ard.bmj.com/content/annrheumdis/early/2021/02/22/annrheumdis-2021-219845.full.pdf?with-ds=yes
Ann Rheum Dis. 2021 Feb 23;annrheumdis-2021-219845. doi: 10.1136/annrheumdis-2021-219845. Online ahead of print
Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients
https://ard.bmj.com/content/annrheumdis/early/2020/12/01/annrheumdis-2020-218310.full.pdf
Ann Rheum Dis. 2020 Dec 2;annrheumdis-2020-218310. doi: 10.1136/annrheumdis-2020-218310. Online ahead of print
Coronavirus disease 2019 outcomes among patients with rheumatic diseases 6 months into the pandemic
https://ard.bmj.com/content/annrheumdis/early/2020/11/29/annrheumdis-2020-219279.full.pdf
Ann Rheum Dis. 2020 Nov 30:annrheumdis-2020-219279. doi: 10.1136/annrheumdis-2020-219279. Online ahead of print
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
https://www.nejm.org/doi/full/10.1056/NEJMoa2023184
https://www.nejm.org/doi/pdf/10.1056/NEJMoa2023184?articleTools=true
Non‐steroidal anti‐inflammatory drugs and susceptibility to COVID‐19
https://onlinelibrary.wiley.com/doi/abs/10.1002/art.41593?campaign=wolacceptedarticle
https://onlinelibrary.wiley.com/doi/epdf/10.1002/art.41593
Arthritis Rheumatol. 2020 Nov 13. doi: 10.1002/art.41593. Online ahead of print.
Antiphospholipid Antibodies in Critically Ill Patients With COVID‐19
https://onlinelibrary.wiley.com/doi/full/10.1002/art.41425?campaign=wolearlyview
https://onlinelibrary.wiley.com/doi/epdf/10.1002/art.41425
Arthritis Rheumatol. 2020 Jun 30:10.1002/art.41425. doi: 10.1002/art.41425. Online ahead of print.
Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis
Ann Rheum Dis. 2020 Oct 13;annrheumdis-2020-218946. doi: 10.1136/annrheumdis-2020-218946. Online ahead of print
https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(20)30305-2/fulltext
https://www.thelancet.com/action/showPdf?pii=S2665-9913%2820%2930305-2
Lancet Rheumatol. 2020 Sep 21. doi: 10.1016/S2665-9913(20)30305-2. Online ahead of print.
Leveraging the United States Epicenter to Provide Insights on COVID‐19 in Patients with Systemic Lupus Erythematosus
https://onlinelibrary.wiley.com/doi/10.1002/art.41450
https://onlinelibrary.wiley.com/doi/epdf/10.1002/art.41450
Antirheumatic Disease Therapies for the Treatment of COVID‐19: A Systematic Review and Meta‐analysis
https://onlinelibrary.wiley.com/doi/10.1002/art.41469
https://onlinelibrary.wiley.com/doi/epdf/10.1002/art.41469
Arthritis Rheumatol. 2020. PMID: 32741139
Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays
https://www.sciencedirect.com/science/article/pii/S1472648320303187?via%3Dihubhttps://www.rbmojournal.com/article/S1472-6483(20)30318-7/fulltext
Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study
https://ard.bmj.com/content/annrheumdis/79/9/1143.full.pdf
Ann Rheum Dis. 2020. PMID: 32719045
Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study
https://ard.bmj.com/content/early/2020/08/12/annrheumdis-2020-218296?utm_source=alert&utm_medium=email&utm_campaign=ard&utm_content=latest&utm_term=15082020
https://ard.bmj.com/content/annrheumdis/early/2020/08/12/annrheumdis-2020-218296.full.pdf
COVID‐19 in Patients with Inflammatory Arthritis: A Prospective Study on the Effects of Comorbidities and DMARDs on Clinical Outcomes
https://onlinelibrary.wiley.com/doi/abs/10.1002/art.41456?campaign=wolacceptedarticle
https://onlinelibrary.wiley.com/doi/epdf/10.1002/art.41456
Arthritis Rheumatol.2020 Jul 28. doi: 10.1002/art.41456. Online ahead of print.
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
https://www.nature.com/articles/s41591-020-0965-6
https://www.nature.com/articles/s41591-020-0965-6.pdf
Nat Med.2020 Jun 18.doi: 10.1038/s41591-020-0965-6.Online ahead of print
Emergency arising from patients' fear of taking antimalarials during these COVID-19 times: are antimalarials as unsafe for cardiovascular health as recent reports suggest?
https://ard.bmj.com/content/annrheumdis/early/2020/07/08/annrheumdis-2020-218259.full.pdf
Ann Rheum Dis. 2020 Jul 9;annrheumdis-2020-218259. doi: 10.1136/annrheumdis-2020-218259. Online ahead of print.
Tocilizumab for treatment of mechanically ventilated patients with COVID-19
https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa954/5870306
Clinical course, severity and mortality in a cohort of patients with COVID-19 with rheumatic diseases
https://ard.bmj.com/content/annrheumdis/early/2020/06/30/annrheumdis-2020-218054.full.pdf
Brief Report: Anti‐phospholipid antibodies in critically ill patients with Coronavirus Disease 2019 (COVID‐19)
https://onlinelibrary.wiley.com/doi/abs/10.1002/art.41425?campaign=wolacceptedarticle
https://onlinelibrary.wiley.com/doi/epdf/10.1002/art.41425
Arthritis Rheumatol. 2020 Jun 30. doi: 10.1002/art.41425. Online ahead of print.
Anti‐cardiolipin IgG autoantibodies are an independent risk factor of COVID‐19 severity
https://onlinelibrary.wiley.com/doi/abs/10.1002/art.41409?campaign=wolacceptedarticle
https://onlinelibrary.wiley.com/doi/epdf/10.1002/art.41409
Arthritis Rheumatol. 2020 Jun 21;10.1002/art.41409. doi: 10.1002/art.41409. Online ahead of print.
Tocilizumab for treatment of patients with severe COVID–19: A retrospective cohort study
https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30162-0/fulltext
https://www.thelancet.com/action/showPdf?pii=S2589-5370%2820%2930162-0
Perspectives of patients with rheumatic diseases in the early phase of COVID‐19
https://onlinelibrary.wiley.com/doi/abs/10.1002/acr.24347?campaign=wolacceptedarticle
https://onlinelibrary.wiley.com/doi/epdf/10.1002/acr.24347
Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort
https://ard.bmj.com/content/early/2020/06/11/annrheumdis-2020-217960
https://ard.bmj.com/content/annrheumdis/early/2020/06/11/annrheumdis-2020-217960.full.pdf
Anakinra for severe forms of COVID-19: a cohort study
https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(20)30164-8/fulltext
https://www.thelancet.com/action/showPdf?pii=S2665-9913%2820%2930164-8
Published:May 29, 2020DOI:https://doi.org/10.1016/S2665-9913(20)30164-8
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
https://www.nejm.org/doi/full/10.1056/NEJMoa2016638
https://www.nejm.org/doi/pdf/10.1056/NEJMoa2016638?articleTools=true
PMID: 32492293 DOI: 10.1056/NEJMoa2016638
COVID-19 and systemic lupus erythematosus: a case series
https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(20)30161-2/fulltext
https://www.thelancet.com/action/showPdf?pii=S2665-9913%2820%2930161-2
Published Online May 26, 2020 https://doi.org/10.1016/ S2665-9913(20)30161-2
Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARSCoV-2 infection and severe COVID-19
https://ard.bmj.com/content/early/2020/05/20/annrheumdis-2020-217690
https://ard.bmj.com/content/annrheumdis/early/2020/05/20/annrheumdis-2020-217690.full.pdf
PMID: 32381561 DOI: 10.1136/annrheumdis-2020-217690
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
https://ard.bmj.com/content/early/2020/05/29/annrheumdis-2020-217871
https://ard.bmj.com/content/annrheumdis/early/2020/05/29/annrheumdis-2020-217871.full.pdf
Treatment adherence of patients with systemic rheumatic diseases in COVID-19 pandemic
https://ard.bmj.com/content/annrheumdis/early/2020/05/31/annrheumdis-2020-217935.full.pdf
Ann Rheum Dis. 2020 May 31;annrheumdis-2020-217935. doi: 10.1136/annrheumdis-2020-217935. Online ahead of print
Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China
https://ard.bmj.com/content/early/2020/05/22/annrheumdis-2020-217627
https://ard.bmj.com/content/annrheumdis/early/2020/05/22/annrheumdis-2020-217627.full.pdf
Ann Rheum Dis: 2020 May 22;annrheumdis-2020-217627. doi: 10.1136/annrheumdis-2020-217627. Online ahead of print.
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(20)30127-2/fulltext
www.thelancet.com/rheumatology. Published online May 7, 2020 https://doi.org/10.1016/S2665-9913(20)30127-2
Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19
https://www.nejm.org/doi/full/10.1056/NEJMc2013656
May 5, 2020 DOI: 10.1056/NEJMc2013656
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
https://www.nejm.org/doi/full/10.1056/NEJMc2007575N Engl J Med. 2020 Apr 23;382(17):e38. doi: 10.1056/NEJMc2007575. Epub 2020 Apr 8.
Covid-19 in Immune-Mediated Inflammatory Diseases - Case Series from New York
https://www.nejm.org/doi/full/10.1056/NEJMc2009567?query=featured_home
- N Engl J Med. 2020 Apr 29. doi: 10.1056/NEJMc2009567. [Epub ahead of print]
Effective treatment of severe COVID-19 patients with tocilizumab
https://www.pnas.org/content/pnas/early/2020/04/27/2005615117.full.pdf
- PNAS first published April 29, 2020 https://doi.org/10.1073/pnas.2005615117
Incidence and clinical course of COVID-19 in patients with connective tissue diseases: a descriptive observational analysis
http://www.jrheum.org/content/jrheum/early/2020/04/24/jrheum.200507.full.pdf
J Rheumatol. 2020 Apr 25. pii: jrheum.200507. doi: 10.3899/jrheum.200507. [Epub ahead of print]
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies
https://ard.bmj.com/content/79/5/667.long
Ann Rheum Dis. 2020 May;79(5):667-668. doi: 10.1136/annrheumdis-2020-217424. Epub 2020 Apr 2.
Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine
https://ard.bmj.com/content/early/2020/04/24/annrheumdis-2020-217566
Ann Rheum Dis. 2020 Apr 24. pii: annrheumdis-2020-217566. doi: 10.1136/annrheumdis-2020-217566. [Epub ahead of print]
Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries.
https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(20)30095-3/fulltext
Lancet Rheumatol. 2020 Apr 16. doi: 10.1016/S2665-9913(20)30095-3. [Epub ahead of print]
Recomendations Regarding COVID-19 Infection in Rheumatic Patients in Greece
https://mjrheum.org/current-issue/newsid792/204, Published 31 Mar 2020
Mediterr J Rheumatol 2020;31(1):6-7
